There are a handful of priorities for radiologists: lowest radiation dosage, highest image quality, optimal workflow, patient satisfaction and software usability. Part of the Cone Health System, Alamance Regional Medical Center‘s (ARMC) partnership with Samsung has made possible a host of positive outcomes for ARMC’s radiology teams and their patients. A recent study revealed that Samsung’s technology was effective in performing reduced-dose X-ray examinations without compromising image quality.

HeartFlow Inc. announced that UnitedHealthcare now covers the HeartFlow FFRct Analysis, extending access to their 45 million beneficiaries. With this new coverage, more than 235 million people in the United States now have access to the HeartFlow Analysis.


Stroke is the fifth leading cause of death in the United States, responsible for more than 140,000 deaths in some of the most recent data.1 When treating stroke patients, perhaps more than any other condition, time is of the essence.


Medical robotics company Neural Analytics Inc. announced that it received CE Mark for its NeuralBot System, a robotic assistance technology which automatically adjusts orientation and position of its ultrasound products under the guidance of a healthcare professional. The system has also received 510(k) clearance from the U.S. Food and Drug Administration (FDA). When used with its previously cleared Lucid M1 Transcranial Doppler Ultrasound System, it can assist clinicians to non-invasively monitor a patient’s brain blood flow characteristics and can provide information to diagnose a variety of neurological disorders.


Nearly every job in the country is subject to certain health and safety regulations. Construction workers must wear hard hats and steel-toed boots on the jobsite. Offices have to display emergency exit signage and mount fire extinguishers. Restaurant employees are required to wash hands often and comply with food safety specifications.



The mobile digital radiography (DR) segment is the largest segment by product type in the global digital mobile DR devices market, according to a recent market study by Future Market Insights.1 The market was estimated to be valued at more than $2 billion in 2017, expanding at a compound annual growth rate (CAGR) of 7 percent over the forecast period. The mobile DR segment’s revenue in the global digital mobile DR devices market is expected to double by 2026. The report also stated that the mobile DR segment is projected to remain the most attractive in the global digital mobile X-ray devices market, with an attractiveness index of 1.8.



The Alliance for Proton Therapy Access (APTA) released a national report in late May revealing the heavy emotional and financial burden that many cancer patients endure when trying to get their insurer’s approval for physician-recommended proton radiation therapy. The report — “Cancer Care Denied: The Broken State of Patient Access to Proton Therapy” — calls on insurance commissioners in all 50 states to adopt and enforce the principles of a Cancer Patients’ Timely Treatment Bill of Rights and hold insurers accountable for providing fair, timely and transparent access to cancer treatment.


According to ResearchAndMarkets.com’s new industry report, the “Medical Imaging Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024,” the global medical imaging market is predicted to grow with a compound annual growth rate (CAGR) of 6.56 percent over the forecast period of 2018-2024.

Subscribe Now